Lurasidone for Pediatric Bipolar Disorder Linked to Decreased Hospitalization Risk
Compared with olanzapine and aripiprazole, lurasidone was linked with lower risk for all-cause and psychiatric hospitalization in pediatric patients.
Compared with olanzapine and aripiprazole, lurasidone was linked with lower risk for all-cause and psychiatric hospitalization in pediatric patients.
Patient groups have issued a joint statement today to urge the Fifth Circuit Court of Appeals to prioritize patient protections as it presides over arguments in the case Texas v United States.